UK BES has completed a viral vector suite facility for Cobra Biologies; a biologies specialist involved in COVID-19 vaccines. Located on Keele University campus, Cobra has invested in upgrading part of its existing development and production facility with 3 viral vector suites The project is a pivotal element of the company's commercial strategy and BES delivered the project four weeks ahead of schedule, despite the challenges of COVID-19. Compliant to ACDP Hazard Group and US BioSafety Level 2, along with FDA, EMA and MHRA standards, the new facilities will allow Cobra to work with customers to develop gene therapy treatments. The refurbishment project involved design and delivery of three grade C processing suites, each specified to contain a class 2 microbiological safety cabinet, for biological manipulations to be carried out in a grade A environment. Scientists will enter the new facilities via a primary change area to gain access to a grade C change area. Processing suites will be accessed via a clean corridor and exited into a 'dirty' corridor back to the primary change area.
展开▼
